http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI0804273-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bde5b9e9cdf33c864bec3d6d6cfd8303
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D451-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-439
filingDate 2008-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5261062bc114298241387d6bea96921
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea8f1941d86f1adaab8a279aa744da4b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_604e28c232a99e9d7c703e8611deb81f
publicationDate 2019-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-PI0804273-B1
titleOfInvention process for preparing scopolamine nasal formulation in powder form, formulation and use
abstract Nasal formulation of scopolamine in powder form, process for its preparation and use. The present invention provides the development of a nasal formulation containing scopolamine in the form of microspheres for motion sickness or travel sickness obtained by applying the spray-drying method.
priorityDate 2008-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154496863
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553385
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426260387
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322677
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID84571
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24832091
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507784
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426260389
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426387251
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID673473
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24832095
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3000322
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485969
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID187

Total number of triples: 31.